senomyx inc (SNMX:NASDAQ GM)
senomyx inc (SNMX) Snapshot
|
Open
$2.10
|
Previous Close
$2.09
|
|
|
Day High
$2.12
|
Day Low
$2.08
|
|
|
52 Week High
03/11/13 - $2.94
|
52 Week Low
01/25/13 - $1.53
|
|
|
Market Cap
85.7M
|
Average Volume 10 Days
126.3K
|
|
|
EPS TTM
$-0.26
|
Shares Outstanding
40.6M
|
|
|
EX-Date
--
|
P/E TM
--
|
|
|
Dividend
--
|
Dividend Yield
--
|
Related News
senomyx inc (SNMX) Related Businessweek News
No Related Businessweek News Foundsenomyx inc (SNMX) Details
Senomyx, Inc. discovers, develops, and commercializes flavor ingredients for the packaged food, beverage, and ingredient supply industries using proprietary taste receptor-based assays and screening technologies. The company’s programs focus on the development of sweet, savory, and salt flavor ingredients; bitter blockers; and cooling agents. It licenses flavor ingredients to its collaborators on an exclusive or co-exclusive basis. Senomyx, Inc. has product discovery and development collaborations with Ajinomoto Co., Inc.; Firmenich SA; Nestlé SA; and PepsiCo, Inc. The company was founded in 1998 and is headquartered in San Diego, California.
senomyx inc (SNMX) Top Compensated Officers
senomyx inc (SNMX) Key Developments
Senomyx Inc. reported unaudited earnings results for the first quarter ended March 31, 2013. For the period, the company reported net loss of $3,008,000 or $0.07 basic and diluted loss per share on revenue of $7,482,000 against net loss of $1,852,000 or $0.05 basic and diluted loss per share on revenue of $8,282,000 a year ago. Loss from operations was $3,019,000 against $1,878,000 a year ago. Development revenues were $6 million in the first quarter of 2013 compared to 7.1 million in the first quarter of 2012. The decrease is primarily due to 2 factors, first related to the initial $20 million in up-front license fees paid to Senomyx’s under the 2009 Sweet Program collaboration with Firmenich. For 2013, the company expects total revenues of $31 million to $34 million, total operating expenses of $41 million to $43 million, of which approximately $4 million is non-cash, stock-based compensation expense, net loss of $8 million to $10 million and basic and diluted net loss of $0.20 to $0.25 per share.
Senomyx Inc., Q1 2013 Earnings Call, Apr 25, 2013
Senomyx Inc. announced that they will report Q1, 2013 results at 9:00 AM, Eastern Standard Time on Apr 25, 2013
| Recently Viewed | |||
| SNMX:US | $2.11 USD | +0.02 | |
| Company | Last | Change |
| GLG Life Tech Corp | C$0.66 CAD | 0.00 |
| PureCircle Ltd | 332.50 GBp | +2.50 |
| Symrise AG | €32.24 EUR | +0.14 |
| Takasago International Corp | ¥547.00 JPY | -21.00 |
| Tate & Lyle PLC | 855.00 GBp | +5.00 |
| View Industry Companies | ||
Industry Analysis
SNMX
Industry Average
| Valuation | SNMX | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 2.8x |
|
| Price/Book | 3.5x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | 1.7x |
|
Post a JobJobs
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
- Northglenn, CO | Office DepotPosted: Mar 01
Sponsored Financial Commentaries
Sponsored Links
To contact SENOMYX INC, please visit www.senomyx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








